A transcriptomic-based tool to predict gemcitabine sensitivity in advanced pancreatic adenocarcinoma. Fraunhoffer N, Chanez B, Teyssedou C. Gastroenterology 2022 Dec 7:S0016-5085(22)01373.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fraunhoffer N, Chanez B, Teyssedou C. A transcriptomic-based tool to predict gemcitabine sensitivity in advanced pancreatic adenocarcinoma. Gastroenterology 2022 Dec 7:S0016-5085(22)01373.
PMID: 36496056